dsm-firmenich completes $10m upgrade to advance US premix operational excellence
By Archie Villaflores
March 16, 2026
Photo Credits: dsm-firmenich official website
dsm-firmenich, a Switzerland-based nutrition, health and beauty company, has finalised a $10 million (€8.7 million) investment programme at its Schenectady premix manufacturing site in the United States according to a Nutraceutical Business Review report.
The company indicated the facility improvements have repositioned the location as a leading premix production centre for the Americas region, offering customers enhanced assurance within a progressively stringent regulatory and commercial landscape.
The Schenectadty operation now functions as one of North America's most sophisticated human health premix manufacturing locations following implementation of refined good manufacturing practice zone configurations, enhanced material flow systems and broadened material conditioning capacity through contemporary powder processing technologies.
The facility redesign prioritised customer requirements by reinforcing quality assurance protocols, elevating operational efficiency metrics and strengthening audit preparedness whilst reducing risk exposure. These developments are designed to accelerate and improve commercialisation reliability across current and future time horizons.
Maximilian Fattinger, Vice President of Premix at dsm-firmenich, characterised the capital deployment as transcending routine facility maintenance. "This investment goes well beyond incremental upgrades or technical improvements—it reflects our commitment to delivering real value for our customers," he stated.
The facility renovation encompassed three strategic investment categories: establishment of industry-leading quality benchmarks through dedicated production environments and environmental controls, achievement of superior operational performance via 35 blending units and consolidated dispensing infrastructure, and advancement of sustainability objectives through contemporary facility configuration and equipment platforms.
The facility enhancements position Schenectady to address developing regulatory and safety requirements whilst diminishing operational risk exposure for customers and maintaining operational continuity throughout audit processes. The site, originally established in 1995, now operates as a platform for expanded customer collaboration.
View the complete article on dsm-firmenich's Schenectady facility upgrade for the full details.
